908 Newsroom

BioPharma Reporter: 908 Devices launches a Rebel-lion in media analyzing

09.05.19

908 Devices launches the Rebel, the first at-line spent cell media analyzer for bioprocess labs

08.10.19

908 Devices poised to modernize upstream bioprocess analytics with a grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)

07.25.19

908 Devices Addresses Emerging Novichok Nerve Agent Threat, Expands Capabilities for MX908 Chemical Detection Device

06.14.19

908 Devices broadens the ZipChip platform, brings new capability to biotherapeutics researchers

06.03.19

Miniaturization: A ‘Renaissance’ for Mass Spectrometers

05.14.19

908 Devices Secures $17.5 Million in Growth Funding

04.29.19

MX908 Used to Identify Substance That Hospitalized Police Officers in MA

03.20.19

908 Devices’ High-Pressure Mass Spectrometry (HPMS) Technology to Power Next-Generation Advanced Chemical Threat Detector for U.S. Department of Defense

01.09.19

Massachusetts Governor Charlie Baker tours new 908 Devices Boston Headquarters

01.08.19

908 Devices’ MX908 out-designs designer drugs, unlocks detection capabilities for more than 2000 fentanyl variants

10.08.18

908 Devices and Hangzhou Just Biotherapeutics Announce Joint Innovation Partnership

07.10.18